Vertex Pharmaceuticals' non-opioid pain medication gets FDA approval
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
news10nbc38m
FDA approves JournaVX, a non-opioid pain relief option for adults
A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...
Historic FDA approval marks first nonopioid breakthrough since Clinton era
The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...
Investor's Business Daily on MSN54m
How Painkillers Could Be Vertex Pharmaceuticals' Next $10 Billion Chapter
Vertex Pharmaceuticals could soon capture $10 billion in sales of non-opioid painkillers, an analyst said Friday as Vertex stock jumped.
Hosted on MSN46m
Non-Opioid Pain Medication Journavx Gets FDA Approval
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
Science News49m
A new kind of non-opioid painkiller gets FDA approval
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
S&P 500 Gains and Losses Today: UGG Footwear Maker Deckers Outdoor Plunges on Weak Outlook
The S&P 500 declined by 0.5% on Friday, Jan. 31, as investors digested the White House’s proposed tariffs on Canada, China, and Mexico.
The Globe and Mail2m
Stocks Climb on Apple Earnings Results and Benign US Inflation News
Vertex Pharmaceuticals (VRTX) is up more than +4% after receiving FDA approval for its non-opioid analgesic Journavx to treat moderate-to-severe acute pain in adults. LPL Financial Holdings (LPLA) is ...
The Globe and Mail3m
Stocks Retreat on Tariff Anxiety
Vertex Pharmaceuticals (VRTX) closed up more than +5% after receiving FDA approval for its non-opioid analgesic Journavx to treat moderate-to-severe acute pain in adults. AbbVie (ABBV) closed up by ...